165 results on '"Lhomme, Catherine"'
Search Results
2. Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2
3. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors
4. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy
5. Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
6. Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants
7. Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 Cases
8. A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma
9. Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy
10. Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging
11. Guidelines for the management of ovarian cancer during pregnancy
12. Effets iatrogènes des traitements radiothérapiques (irradiation externe et/ou curiéthérapie) et chimiothérapiques sur la fertilité
13. Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease
14. Patterns of care and outcome in elderly cervical cancer patients: A special focus on brachytherapy
15. The PI3K/Akt/mTOR Pathway in Ovarian Cancer: Biological Rationale and Therapeutic Opportunities
16. Endometrial disorders in patients with peritoneal serous papillary carcinoma
17. Exclusive radiotherapy for primary squamous cell carcinoma of the vagina
18. Results of Hysterectomy in Patients With Bulky Residual Disease at the End of Chemoradiotherapy for Stage IB2/II Cervical Carcinoma
19. Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx[R]) in combination with topotecan in patients with advanced malignancies
20. Malignant Adnexal Masses in Pregnancy
21. Cutaneous side-effects of kinase inhibitors and blocking antibodies
22. Successful Treatment for Advanced Small Cell Carcinoma of the Ovary
23. Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases
24. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer
25. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
26. Results of conservative treatment in epithelial ovarian carcinoma
27. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study
28. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
29. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]
30. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers
31. Pooled analysis of onapristone extended release (ONA ER) in metastatic cancer patients (pts): A review of liver safety.
32. Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
33. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies
34. Malignant effusions and immunogenic tumour-derived exosomes
35. Prognostic value of lymph node involvement in ovarian serous borderline tumors
36. Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum alpha-inhibin and estradiol
37. Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients
38. Prognostic Significance of Epithelial Disorders Adjacent to Invasive Vulvar Carcinomas
39. Retroperitoneal drainage after complete Para-aortic lymphadenectomy for gynecologic cancer: a randomized trial
40. Prise en charge du cancer du col de l’utérus métastatique et/ou en rechute
41. Préservation de la fertilité, contraception et traitement hormonal de la ménopause chez les femmes traitées pour tumeurs malignes rares de l’ovaire : recommandations du réseau national dédié aux cancers gynécologiques rares (TMRG/GINECO)
42. Abstract B02: DNA repair landscape in High Grade Ovarian Cancer (HGOC) and evolution with neo-adjuvant chemotherapy
43. Pattern of tumor-infiltrating lymphocytes (TILs) and PD-L1 expression in primary and metastatic epithelial ovarian cancer (EOC).
44. Chapitre 27 - Cancers génitaux, fertilité et grossesse
45. Chapitre 22 - Les tumeurs de l'ovaire à la limite de la malignité
46. Genomic instability (GI) score post-neoadjuvant chemotherapy (NACT) to predict overall survival (OS) in high grade ovarian cancer (HGSOC).
47. Tumor-infiltrating lymphocytes (TILs) and PDL1 expression in ovarian cancer (OC): Evolution with neoadjuvant chemotherapy (NCT) and prognostic value.
48. Abstract A1-27: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) beyond SMARCA4 mutations: A comprehensive genomic analysis
49. Genomic profile and immune infiltrate in paired ovarian cancer (OC) samples pre- and post-neoadjuvant chemotherapy (NC).
50. Onapristone (ONA) in progesterone receptor (PR)-expressing tumors: Efficacy and biomarker results of a dose-escalation phase 1 study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.